Company: Dr. Reddy's Laboratories Ltd. Category: Company News


The Hyderabad-based company is an outlier among large pharmaceutical producers, having seen a jump in its stock price over the previous year
Sept. 22, 2019, 11:44 p.m.

Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach
Sept. 22, 2019, 12:05 p.m.

The EMEND for Injection brand had an U.S. sales of approximately $279mn MAT for the most recent twelve months ending in July 2019 according to IQVIA Health.
Sept. 11, 2019, 2:41 p.m.

Shares of the pharma major are trading higher by ~3% currently.
Sept. 5, 2019, 1:05 p.m.


Pharma major Dr Reddy’s scrip falls 1.97 per cent to Rs 2,504.50 in the afternoon trade on the Bombay Stock Exchange on Wednesday.The Hyderabad-based
Aug. 21, 2019, 12:34 p.m.

Dr Reddy's says it will address the observations comprehensively within the stipulated timeline.Shares of Dr Reddy's Laboratories rise 1.77% to close at Rs2,554.90 per scrip on the BSE
Aug. 20, 2019, 8:39 p.m.
Publisher: livemint.com

Pharma major Dr. Reddy’s Laboratories Ltd has launched Vigabatrin Powder for Oral Solution in the US market.It is a therapeutic equivalent generic ve
Aug. 20, 2019, 2:14 p.m.

Pharma major Dr. Reddy’s Laboratories Ltd has launched ‘Versavo (bevacizumab)’, a biosimilar of Roche’s Avastin in India. The drug is for the treatmen
Aug. 19, 2019, 2:35 p.m.

Avastin and its biosimilars had India sales of approximately Rs223cr MAT for the most recent twelve months ending in December 2018, according to lpsos.
Aug. 19, 2019, 12:59 p.m.

The Nifty Pharma index dropped 3% led by losses seen in Dr Reddys, Glenmark and Sun Pharma.
Aug. 14, 2019, 9:37 a.m.

-->